Skip to content
value.today

Dermapharm Holding SE vs Hypera S.A.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Hypera S.A. is the larger company by market value: $2.5 B against $2.3 B for Dermapharm Holding SE, 1.1 times as much (market caps of Aug 1, 2026 for Dermapharm Holding SE and Nov 19, 2026 for Hypera S.A.). Dermapharm Holding SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Hypera S.A.'s value is an estimate (B3 São Paulo close of 19 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026).
  • Hypera S.A. had more revenue: $1.6 B against $1.1 B for Dermapharm Holding SE, both in the year to December 2022.
  • Hypera S.A. earned more: net income of $359 M against $148 M for Dermapharm Holding SE.
  • Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against 13.1% for Dermapharm Holding SE.
  • Hypera S.A. employs more people: 9,000 against 3,497 at Dermapharm Holding SE. Each employee brings in about $322,848 of revenue at Dermapharm Holding SE and $177,222 at Hypera S.A.
  • On price to earnings, Dermapharm Holding SE trades at 15.7× and Hypera S.A. at 6.9×: investors pay more for each dollar of Dermapharm Holding SE's profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0501001502002020202120222023202420252026Dermapharm Holding SE 97Hypera S.A. 42

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$1B$1B$1B20162017201820192020202120222023Dermapharm Holding SE $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureDermapharm Holding SE
DMP.F · #5,838 in the world
Hypera S.A.
HYPE3.SA · #5,624 in the world
Profile
Country🇩🇪 Germany🇧🇷 Brazil
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19912001
Size
Market cap$2.3 B$2.5 B
Revenue$1.1 B$1.6 B
Net income$148 M$359 M▲ best
Employees3,4979,000
Valuation
P/E ratio15.7×6.9×
Price to sales2.1×1.6×
Price to book4.0×1.1×
Altman Z-score zone——
Data as ofMarket cap Aug 2026; ratios FY2025Market cap Nov 2026

Questions and answers#

Which is bigger, Dermapharm Holding SE or Hypera S.A.?

Hypera S.A. is the larger company by market value: $2.5 B against $2.3 B for Dermapharm Holding SE, 1.1 times as much (market caps of Aug 1, 2026 for Dermapharm Holding SE and Nov 19, 2026 for Hypera S.A.). Dermapharm Holding SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Hypera S.A.'s value is an estimate (B3 São Paulo close of 19 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026).

Which makes more money, Dermapharm Holding SE or Hypera S.A.?

Hypera S.A. had more revenue: $1.6 B against $1.1 B for Dermapharm Holding SE, both in the year to December 2022. Hypera S.A. earned more: net income of $359 M against $148 M for Dermapharm Holding SE.

Which is more profitable, Dermapharm Holding SE or Hypera S.A.?

Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against 13.1% for Dermapharm Holding SE.

Which has more employees, Dermapharm Holding SE or Hypera S.A.?

Hypera S.A. employs more people: 9,000 against 3,497 at Dermapharm Holding SE. Each employee brings in about $322,848 of revenue at Dermapharm Holding SE and $177,222 at Hypera S.A.

Is Dermapharm Holding SE cheaper than Hypera S.A.?

On price to earnings, Dermapharm Holding SE trades at 15.7× and Hypera S.A. at 6.9×: investors pay more for each dollar of Dermapharm Holding SE's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.